|
VesicareDrug - Vesicare The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
Active Ingredient(s) -
Solifenacin Succinate
Strength -
10MG
Applicant -
ASTELLAS
New Drug Application (NDA) Number -
021518
Product Number -
002
Therapeutic Equivalence (TE) Code -
Approval Date -
Nov 19, 2004
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Astellas Pharma Us Inc
Vesicare
Sodium Polystyrene Sulfonate 15gm/60ml Suspension; Oral, Rectal
Sodium Polystyrene Sulfonate 15gm/60ml Suspension; Oral, Rectal Sps 15gm/60ml Suspension; Oral, Rectal Sodium Succinate 30% Injectable; Injection Sotradecol 20mg/2ml (10mg/ml) Injectable; Injection Sotradecol 60mg/2ml (30mg/ml) Injectable; Injection Sotradecol 1% **federal Register Determination That Product Was Not Discontinued Or Withdrawn For Safety Or Efficacy Reasons** Injectable; Injection Sotradecol 3% **federal Register Determination That Product Was Not Discontinued Or Withdrawn For Safety Or Efficacy Reasons** Injectable; Injection Sodium Thiosulfate 250mg/ml Injectable; Injection Vesicare 10mg Tablet; Oral NewDrugInformation |